+1 7178835943 [email protected]
Hybrid Event (In-person or Virtual participation)

International Conference on Viral Infection and Immune Response · Registering as Listener

ICVIIR
📅 20 – 21 Feb 2027 📍 Paris, France 👥 Standard / Physical Participation
Listener Registration From
$185
Registration Benefits:
Official invitation letterIssued automatically after registration
🎖 Certificate & digital materialsGet certificate, slides and resource materials
🌐 Supporting global researchConnect with researchers across 30+ countries

Select registration mode

Prices are shown before tax and bank charges — no surprises at checkout.

All sessions Networking Certificate Invitation letter Conference kit

Your details

We only need what's required to register and email your confirmation. Everything else is optional.

Coupon Code (If Any)

Have a code? Apply it here — the discount updates the total immediately.

🏷

For Support Please Contact

VISAMASTERCARDNET BANKINGUPI

Payments encrypted & processed securely. Refundable up to 14 days before the event.

Registration summary

ConferenceInternational Conference on Viral Infection and Immune Response
ModeStandard / Physical
ParticipationListener
Registration fee$185.00
Bank charges (5.8%)$10.73
Total payable $195.73

Includes all bank processing charges — the amount above is exactly what will be charged.

Need help?

Contact our registration team:

📞 +91 93445 35349

Benefits of Registering as Listener

👥Access to Conference Sessions
🔗Networking Opportunities
🎖Certificate of Participation
Invitation Letter Support
📚Conference Kit / Materials
🎤Access to Keynote Sessions
• Conference Session Tracks •
SDG

SDG-Aligned Research Themes

Conference tracks support global knowledge exchange, innovation, and sustainable development priorities across diverse disciplines.

SDG 3 SDG 4 SDG 9 SDG 10

This track focuses on the mechanisms of viral pathogenesis and the latest advancements in treatment strategies for various viral infectious diseases. Discussions will include antiviral therapies, vaccine development, and emerging treatment modalities.

This session will explore the molecular epidemiology of viral infections, emphasizing the genetic and environmental factors influencing viral spread and evolution. Researchers will present findings on viral transmission dynamics and population genetics.

This track addresses the public health implications of zoonotic viral diseases, highlighting the transmission pathways from animals to humans. Participants will discuss prevention strategies, surveillance, and control measures.

This session will examine the human immune response to viral infections, including innate and adaptive immunity. Topics will cover immune evasion strategies employed by viruses and the implications for vaccine design.

This track will focus on public health practices aimed at controlling viral infections, including outbreak response, vaccination campaigns, and health education. Case studies will illustrate successful interventions and challenges faced in various settings.

This session will highlight the importance of surveillance systems in detecting and responding to emerging viral threats. Discussions will include global collaboration, data sharing, and the role of technology in outbreak prediction.

This track will delve into the latest innovations in vaccine development for viral diseases, addressing both traditional and novel approaches. Challenges in vaccine distribution, public acceptance, and efficacy will also be discussed.

This session will explore the ethical implications of research and public health interventions related to viral infections. Topics will include informed consent, equity in vaccine distribution, and the balance between individual rights and community health.

This track will focus on viral hemorrhagic fevers, examining clinical presentations, epidemiological trends, and management strategies. Experts will discuss the challenges of diagnosing and treating these severe infections.

This session will cover the latest research on viral hepatitis, including epidemiology, pathogenesis, and treatment options. Discussions will highlight advancements in antiviral therapies and the impact of hepatitis on public health.

This track will address the impact of respiratory viruses on global health, focusing on influenza, coronaviruses, and other respiratory pathogens. Participants will discuss prevention strategies, vaccine development, and the implications for public health policy.

COPYRIGHT © 2026 ISAR. ALL RIGHTS RESERVED